We are actually removing SCV02 from our clinical pathway. It was a hard decision and actually came down to the fact that the ED docs wanted those central lines for rapid injection contrast in CT, to look for sources. You can’t have both. We couldn’t get the company to tell us the SCVo2 line was safe for rapid injection. So since our Intensivists did not utilize the data from the SCV02 consistently, we removed it from our pathway. It was really a fight. So we will see how it goes and how our data turns out. Guess time will tell?? ☺
From: Sepsisgroups [mailto:[email protected]] On Behalf Of [email protected] Sent: Thursday, July 17, 2014 9:21 AM To: Sue Beswick Cc: [email protected] Subject: Re: [Sepsis Groups] Impact of ProCESS study on your protocols Not yet, but I have noticed that continuous ScVO2 monitoring hasn't made much of a difference. Hesham A. Hassaballa, MD, FCCP Program Medical Director Critical Care Rush-Copley Medical Center Assistant Professor of Medicine Rush University Medical Center Phone: (331) 454-6572 On Jul 17, 2014, at 10:13 AM, "Sue Beswick" <[email protected]<mailto:[email protected]>> wrote: Is anyone adapting their protocols with the findings that came out this year with the ProCESS study? We are looking at making some changes. Sue Sue Beswick APRN, MS, CCNS, CCRN CNS Critical Care Greenville Health System 701 Grove Road l Greenville, SC 29605 Office: 864-455-4884 _______________________ ________________________ Sepsisgroups mailing list [email protected]<mailto:[email protected]> http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org<https://urldefense.proofpoint.com/v1/url?u=http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org&k=gvSHeaFBHkYwSc4JvWghxQ%3D%3D%0A&r=egaKiPQ%2Brdwqr5Y0ugXX3GDQH6Tbc%2BHQdD8DIzjfxAc%3D%0A&m=65sx5MeGEbf0qvQRIuDbBvQk%2B6VZIJXpsrISu4Z1Fec%3D%0A&s=2bf86b767b445fdc45e22be222b07a0fae99b12b4f7676a4e744ea124e681497> This message, including any attachments, is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply email and destroy all copies of the original message. ---------------------------------------------------------------------- Regional Health's mission is to provide and support health care excellence in partnership with the communities we serve. Note: The information contained in this message, including any attachments, may be privileged, confidential, or protected from disclosure under state or federal laws . If the reader of this message is not the intended recipient, or an employee or agent responsible for delivering this message to the intended recipient, you are hereby notified that any dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, please notify the Sender immediately by a "reply to sender only" message and destroy all electronic or paper copies of the communication, including any attachments.
_______________________________________________ Sepsisgroups mailing list [email protected] http://lists.sepsisgroups.org/listinfo.cgi/sepsisgroups-sepsisgroups.org
